Zynerba Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. Zynerba Pharmaceuticals shares (ZYNE) are listed on the NASDAQ and all prices are listed in US Dollars. Zynerba Pharmaceuticals employs 25 staff and has a trailing 12-month revenue of around $86,000.
Our top picks for where to buy Zynerba Pharmaceuticals stock
How to buy Zynerba Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ZYNE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Zynerba Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Zynerba Pharmaceuticals stock price (NASDAQ: ZYNE)
Use our graph to track the performance of ZYNE stocks over time.Zynerba Pharmaceuticals shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.33 - $1.40 |
50-day moving average | $1.21 |
200-day moving average | $0.62 |
Wall St. target price | $1.25 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.79 |
Is it a good time to buy Zynerba Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Zynerba Pharmaceuticals price performance over time
Historical closes compared with the close of $0 from 2023-11-08
1 week (2024-07-16) | nan% |
---|---|
1 month (2024-06-23) | nan% |
3 months (2024-04-23) | nan% |
6 months (2024-01-23) | nan% |
1 year (2023-07-27) | -100.00% |
---|---|
2 years (2022-07-27) | -100.00% |
3 years (2021-07-27) | 4.53 |
5 years (2019-07-26) | 11.31 |
Zynerba Pharmaceuticals financials
Revenue TTM | $86,000 |
---|---|
Gross profit TTM | $0 |
Return on assets TTM | -45.11% |
Return on equity TTM | -87.13% |
Profit margin | 0% |
Book value | $0.58 |
Market Capitalization | $70.1 million |
TTM: trailing 12 months
Zynerba Pharmaceuticals share dividends
We're not expecting Zynerba Pharmaceuticals to pay a dividend over the next 12 months.
Zynerba Pharmaceuticals share price volatility
Over the last 12 months, Zynerba Pharmaceuticals's shares have ranged in value from as little as $0.3321 up to $1.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zynerba Pharmaceuticals's is 1.1932. This would suggest that Zynerba Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Zynerba Pharmaceuticals overview
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014.
Frequently asked questions
What percentage of Zynerba Pharmaceuticals is owned by insiders or institutions?Currently 6.07% of Zynerba Pharmaceuticals shares are held by insiders and 12.127% by institutions. How many people work for Zynerba Pharmaceuticals?
Latest data suggests 25 work at Zynerba Pharmaceuticals. When does the fiscal year end for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals's fiscal year ends in December. Where is Zynerba Pharmaceuticals based?
Zynerba Pharmaceuticals's address is: 80 West Lancaster Avenue, Devon, PA, United States, 19333 What is Zynerba Pharmaceuticals's ISIN number?
Zynerba Pharmaceuticals's international securities identification number is: US98986X1090 What is Zynerba Pharmaceuticals's CUSIP number?
Zynerba Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98986X109
More guides on Finder
-
Options trading strategies for beginners
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question